UNH has lost more than $200 billion in market value in the last six months. The company’s old CEO sees a fix. Investors ...

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic ...

The Inflation Reduction Act (IRA), which included many changes to Medicare Part D prescription drug benefits, improved ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

Diversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Policymakers are increasingly focused on reforming prior authorization to reduce administrative burdens and improve patient ...

President Donald Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key ...

As Congress deliberates these proposals, the potential impact on taxpayers, businesses, and the broader economy remains a ...

Reps. Jack Bergman (R-Mich.) and Lou Correa (D-Calif.), who co-chair the Congressional Psychedelic Advancing Therapies Caucus ...

As Maryland negotiates a new health care system, federal government may cut back state’s control over Medicare costs.

Protecting Cherokee Nation's sovereignty requires constant vigilance, particularly in ensuring the federal government upholds ...